收费全文 | 336069篇 |
免费 | 22241篇 |
国内免费 | 7371篇 |
耳鼻咽喉 | 4055篇 |
儿科学 | 9523篇 |
妇产科学 | 6541篇 |
基础医学 | 27358篇 |
口腔科学 | 7923篇 |
临床医学 | 36843篇 |
内科学 | 41990篇 |
皮肤病学 | 4556篇 |
神经病学 | 19235篇 |
特种医学 | 7788篇 |
外国民族医学 | 31篇 |
外科学 | 36144篇 |
综合类 | 50301篇 |
现状与发展 | 12篇 |
一般理论 | 29篇 |
预防医学 | 34110篇 |
眼科学 | 5236篇 |
药学 | 29879篇 |
371篇 | |
中国医学 | 30388篇 |
肿瘤学 | 13368篇 |
2023年 | 5228篇 |
2022年 | 8618篇 |
2021年 | 13025篇 |
2020年 | 12095篇 |
2019年 | 18005篇 |
2018年 | 15714篇 |
2017年 | 12603篇 |
2016年 | 10118篇 |
2015年 | 9444篇 |
2014年 | 19530篇 |
2013年 | 21062篇 |
2012年 | 17971篇 |
2011年 | 19463篇 |
2010年 | 15625篇 |
2009年 | 14334篇 |
2008年 | 13978篇 |
2007年 | 14471篇 |
2006年 | 12614篇 |
2005年 | 10962篇 |
2004年 | 8925篇 |
2003年 | 7850篇 |
2002年 | 6137篇 |
2001年 | 5534篇 |
2000年 | 4573篇 |
1999年 | 3974篇 |
1998年 | 3219篇 |
1997年 | 3078篇 |
1996年 | 2666篇 |
1995年 | 2567篇 |
1994年 | 2477篇 |
1993年 | 1972篇 |
1992年 | 2004篇 |
1991年 | 1728篇 |
1990年 | 1539篇 |
1989年 | 1370篇 |
1988年 | 1301篇 |
1987年 | 1120篇 |
1985年 | 3787篇 |
1984年 | 4796篇 |
1983年 | 3340篇 |
1982年 | 3805篇 |
1981年 | 3547篇 |
1980年 | 3159篇 |
1979年 | 2906篇 |
1978年 | 2536篇 |
1977年 | 1907篇 |
1976年 | 2150篇 |
1975年 | 1636篇 |
1974年 | 1433篇 |
1973年 | 1279篇 |
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献Methods: Using the Schedule for Clinical Assessment in Neuropsychiatry, tedium vitae was assessed in 130 stroke survivors attending rehabilitation in a large Nigerian university hospital. Global cognitive and executive dysfunctions were evaluated, respectively, using the Mini Mental State Examination and the modi?ed Indiana University Token test. All participants had their index stroke 3 to 24 months before recruitment into the study. We also examined a comparative group of 130 age, gender, and education matched apparently normal persons who were unrelated to the stroke survivors. Associations were explored using univariate and multivariate logistic regression analyses.
Results: Tedium vitae was experienced by 16 (12.3%) stroke survivors compared with 5 (3.9%) in the comparative group (O. R = 3.5, 95% C. I = 1.3–9.9, p = 0.018). Among stroke survivors, those who were retired were more likely to experience tedium vitae (56.2%, p = 0.045). In analyses adjusting for the effect of systemic hypertension, cognitive dysfunction, retirement and marital separation, there was a 3.5-fold increase in the odds of experiencing tedium vitae after surviving a stroke (O. R = 3.5, 95% C. I = 1.1–11.6, p = 0.042).
Conclusions: Tedium vitae is a common suicidal experience after stroke and may be among the earliest perceptible pointer to impending poststroke suicide. It is easy to assess and may be less costly to obtain an adequate sample size in studies aiming to understand the phenomenon of suicide in the stroke population. 相似文献